⌘K

Login Start Free

Home/Insiders/McKechnie Duncan

MD

SEC Insider//CIK 0002062139

McKechnie Duncan

CIK 00020621391 companyBOSTON, MA

Transactions

10

Companies

1

Filings

6

CIK

0002062139

Recent Transactions

10 trades

Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2026-03-04$475.30/sh−2,437→ 15,122 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2026-02-25$489.00/sh−2,410→ 17,559 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2026-02-25$486.35/sh−2,500→ 19,969 total
Tax Payment
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2026-02-24$485.11/sh−873→ 22,469 total
Tax Payment
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2026-02-17$483.75/sh−1,148→ 23,342 total
Award
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2026-02-17+4,962→ 24,490 total
Tax Payment
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2026-02-13$487.76/sh−2,283→ 19,528 total
Tax Payment
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2026-02-10$468.41/sh−1,127→ 21,811 total
Award
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2026-01-22+4,720→ 20,858 total
Award
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2026-01-22+2,080→ 22,938 total

Companies

1

VERTEX PHARMACEUTICALS INC / MA
EVP, Chief Commercial Officer
$VRTX

Recent Filings

6

Address

C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE

BOSTON, MA, 02210

View on SEC.gov